Funding Details
- Awarder
- Inbox
- Date Award
- January 11, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$120,000,000
Company Info
- Organizations Involved
- GSK, UPMC Enterprises
- Founders
- Monograph Capital
- Company Description
- Ouro Medicines is a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases.
- Market
- Chronic immune-mediated diseases
- Location
-
San Francisco,
California,
USA
- Coinvestors
- TPG Life Sciences Innovations, NEA, Norwest Venture Partners, Monograph Capital, GSK, UPMC Enterprises, Boyu/Zoo Capital, LongRiver Investments
Links